Vaccinia virus-based vaccines mount a robust immune response against the monkeypox virus

New research has suggested that recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the monkeypox virus observed in the current outbreak (MPXV-2022).

Related Keywords

Australia ,Melbourne ,Victoria ,Hong Kong ,Australian ,Matthew Mckay ,Ahmed Abdul ,Emily Henderson ,Australian Research Council Future Fellowship ,Research Assistant Professor ,University Of Melbourne Prof ,Immunity Doherty Institute ,World Health Organization ,Hong Kong University Of Science ,Peter Doherty Institute For Infection ,Professorial Fellow ,Peter Doherty Institute ,Doherty Institute ,Hong Kong University ,Adjunct Professor ,General Research Fund ,Hong Kong Research Grants Council ,Monkeypox ,Research ,Vaccine ,Virus ,Antibodies ,Efficacy ,Enetic ,Enomic ,Immune Response ,Immunity ,Vaccinia Virus ,